A Phase 4 interventional study of Rapid Diagnostic Test for P. falciparum malaria in Malaria, sponsored by Karolinska University Hospital. Completed at 1 site in Tanzania. Per ClinicalTrials.gov, last updated 2007-10-25.
Sponsored by Karolinska University Hospital · Phase 4, Interventional, and Diagnostic
The purpose of this study is to assess performance and cost-effectiveness of rapid diagnostic test(RDT) aided malaria diagnosis versus symptom-based/clinical diagnosis in patients of all ages with reported fever last 48 hours alone in primary health care settings in Zanzibar.
1,299 studies on the registry are indexed under Malaria; 86 are open to participants now.
This study's enrollment of 9,346 is above the median of 220 across 1,027 interventional studies indexed under Malaria.
Browse Malaria studies →Karolinska University Hospital is the lead sponsor of 275 studies on the registry; 54 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Also known as: Paracheck Pf, Manufactured by Orchid Biomedical Systems, Goa, INDIA.
This study is completed, as verified in Oct 2007. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Karolinska University Hospital